Latham & Watkins Advises on BrightSpring’s US$304.5 Million Secondary Offering of Common Stock

BrightSpring Health Services, Inc. (NASDAQ: BTSG) (BrightSpring), a leading provider of home and community-based health services for complex populations, has announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the Selling Stockholders), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the KKR Selling Stockholder) and certain members of management, of an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the US Securities and Exchange Commission, at the public offering price of US$21.75 per share. The KKR Selling Stockholder has granted the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of BrightSpring’s common stock. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering. The offering closed on June 12, 2025.

Latham & Watkins LLP represents the underwriters in the offering with a capital markets team led by New York partners Marc Jaffe and Ian Schuman, with associates Kaj Nielsen, Angel Marcial, and Vanessa Hillabrand, with assistance from Harris Scott. Advice was also provided on healthcare matters by Washington, D.C. counsel Nicole Liffrig Molife, with associates Heather Modiano, Margaret Rote, and Megan Lich; on intellectual property matters by New York counsel Carrie Girgenti; on data privacy matters by Bay Area partner Heather Deixler, with associate Kathryn Parsons-Reponte; and on tax matters by New York partner Elena Romanova, with assistance from Jack Santoro.